Forbes -
4 Apr 2016 19:26
In trading on Monday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 3.5% on the day. Components of that ETF showing particular strength include shares of Celldex Therapeutics (CLDX), up about 11.1% and shares of Anacor Pharmaceuticals (ANAC), up about 9.8% on the day.
Share this Article
Comment on this Article
Please to comment